Search - tctmd.com

Displaying 701 - 720 of 867

Sort: Relevancy | Date

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Conference News VIVA 2016

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Industry News

Lombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy

June 14, 2016

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Industry News

Tips for Convincing Your Boss to Attend TCT 2016

April 13, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss

Michael O'Riordan

April 04, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

Presentation

AHA Late Breaking Trials: What's more appropriate? IVUS or appropriate use criteria?

Presenter: Gregg W. Stone

January 19, 2016

Presentation

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

Presenter: Gregg W. Stone

November 23, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

Advertisement

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

TCTMD’s Top 10 Most Popular Stories for June 2016

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Lombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Tips for Convincing Your Boss to Attend TCT 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

AHA Late Breaking Trials: What's more appropriate? IVUS or appropriate use criteria?

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content